Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the University of Oxford teamed up with the Angolan Ministry of Health to study the introduction and circulation of the Asian genotype of Zika virus in Angola, southwestern Africa. The Asian genotype caused the 2015-16 epidemic of microcephaly and other birth defects in the Americas.

Their findings are published today in The Lancet Infectious Diseases.

In 2017 Angola started reporting cases of microcephaly in newborns. Until that point only the African genotype of Zika was known to circulate in Africa.

Researchers from Oxford’s Department of Zoology and the Instituto Nacional de Investigação em Saúde in Luanda, followed up on reports of microcephaly cases in Angola, which they suspected could be caused by Zika virus infection in pregnancy. They carried out molecular testing and genome sequencing to understand the virus’s genetic history and its epidemiology in this ground-breaking genomic detective work. This is the first time that complete virus genomes have been generated on-site in Angola.

Read more (University of Oxford website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.